leadf
logo-loader
viewInnoCan Pharma

Innocan Pharma received U.S. FDA approval for their over the counter CBD pain relief line

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the United States for their patent-pending CBD Relief &GO pain relief collection.

Bincovich talks about the collection and when they would like to have it in stores and online. She also discussed the latest on their research into Covid-19.

Quick facts: InnoCan Pharma

Price: 0.45 CAD

CSE:INNO
Market: CSE
Market Cap: $79.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Loop Insights getting ready to rumble as platform wallet being used by the...

Loop Insights (CVE: MTRX- OTCQB: RACMF) CEO Rob Anson joined Steve Darling from Proactive with big news that Loop's Wallet pass platform will engage global boxing fans during the WBC super-middleweight championship fight, featuring champion Saul "Canelo" Alvarez and challenger Avni...

1 day, 2 hours ago

2 min read